Management of hypotension in dihydropyridine calcium channel blocker overdose: The role of high‐dose insulin therapy
British Journal of Clinical Pharmacology · 2025-09 · 91 (9) · 2613-2620
DOI: 10.1002/bcp.70081 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 27.04.2025. Verfasst von Betty S H Chan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Toxicology, Prince of Wales Hospital, Sydney, Australia. Hauptthemen laut MEDLINE: Hypotension, Calcium Channel Blockers, Drug Overdose, Insulin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims
Amlodipine poisoning is a leading cause of cardiovascular medication‐related deaths, commonly managed with high‐dose insulin (HDI) therapy. However, HDI is a vasodilator that is counterproductive in managing vasoplegia. We aim to study HDI therapy in patients with hypotension following dihydropyridine calcium channel antagonist (CCA) overdose.
Methods
This retrospective study includes adult patients (≥15 years) with deliberate dihydropyridine CCA overdose and hypotension (mean arterial pressure
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Toxicology, Prince of Wales Hospital, Sydney, Australia.
- New South Wales Poisons Information Centre, Sydney Children's Hospitals Network, Westmead, Australia.
- Queensland Poisons Information Centre, Queensland Children's Hospital, Brisbane, Australia.
- Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Australia.
- Edith Collins Centre, Drug Health Services, Royal Prince Alfred Hospital, Sydney, Australia.
- Emergency Dept, Hospital Tengku Ampuan Rahimah, Klang, Malaysia.
ORCID-Profile: Betty S H Chan, Darren M Roberts
Zitieren
APA
Chan, B. S. H., Isoardi, K. Z., Roberts, D. M., & Har, O. S. (2025). Management of hypotension in dihydropyridine calcium channel blocker overdose: The role of high‐dose insulin therapy. British Journal of Clinical Pharmacology, 91(9), 2613-2620. https://doi.org/10.1002/bcp.70081
Vancouver
Chan BSH, Isoardi KZ, Roberts DM, Har OS. Management of hypotension in dihydropyridine calcium channel blocker overdose: The role of high‐dose insulin therapy. British Journal of Clinical Pharmacology. 2025;91(9):2613-2620. doi:10.1002/bcp.70081
BibTeX
@article{Chan2025,
author = {Chan, Betty S H and Isoardi, Katherine Z and Roberts, Darren M and Har, Ong Sook},
title = {Management of hypotension in dihydropyridine calcium channel blocker overdose: The role of high‐dose insulin therapy},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
volume = {91},
number = {9},
pages = {2613--2620},
doi = {10.1002/bcp.70081}
}
EUVIMED